Successfully Implement PAT Across the Drug Development Lifecycle to Increase Automation and Drive Cost Efficiency
Welcome to the 3rd PAT & Real Time Quality Summit
With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it’s time to make the most of evolving process analytical technology (PAT) to design robust and cost-effective control strategies to understand more about your biopharmaceutical products.Â
Recent blockbusters like GLP-1 peptides have sparked unprecedented investment into advanced manufacturing strategies, such as Novo Nordisk’s recent $11B acquisition to expand manufacturing capacity. The maturity of PAT tools and the development of sophisticated software and chemometrics now provide the perfect opportunity to revolutionize traditional quality and analytical approaches, achieving the digital manufacturing maturity necessary for the future.Â
Join over 100 leading PAT scientists, engineers, process development, CMC, MSAT and quality experts at the 3rd Annual PAT & Real Time Quality Summit. Explore cutting-edge data-driven case studies, engage in dynamic roundtables and deep dive into KOL-led panel debates. This summit is your gateway to staying ahead of the innovation curve, exceeding stakeholder expectations for faster time to market, and unlocking significant ROI through transformative PAT and real-time quality control.
Don’t miss your chance to connect groundbreaking technologies with real-world manufacturing investment decisions. This is the only PAT conference designed exclusively for the pharmaceutical and biopharmaceutical community, where insights turn into action.
Expert Speakers Include:
Previously Attending Companies Include:
What Makes Us Different?
"A good balance between talks, networking, and roundtables. The relatively small size allowed for good conversations. The roundtable discussions were helpful in learning what others in the field are working on."
2nd PAT & Real Time Quality Attendee, Senior Vice President - Scientific & Business Operations, LumaCyte
"Unlike many other professional conferences I have attended, this one had a much more collaborative environment. The information was helpful, but the peer insight was unique at this event."
2nd PAT & Real Time Quality Attendee, Senior Principal Development Engineer, Noven PharmaceuticalsÂ
"Well attended with representatives from companies that are highly influential in the PAT space. Small enough of a show to make networking with others comfortable. Plenty of opportunities to share thoughts with others."
2nd PAT & Real Time Quality Attendee, Sales & Business Development Manager, Optimal Industrial TechnologiesÂ
Our Partners:
